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According to estimations of the World Health
Organisation, the prevalence of diabetes mellitus in
adults will rise from 4% in 1995 to 5,4% in 2025 [1].
This will give a substantial impact on the cardiovas-
cular health care of these patients. Several studies
showed, that the presence of diabetes mellitus is
independently associated with a doubling of cardio-
vascular risk in men and a threefold increase of
cardiovascular risk in women and accounts for about
70% of all deaths in these patients [2, 3]. Death in
diabetic patients is mainly attributable to coronary
artery disease, left ventricular hypertrophy and left
ventricular dysfunction [1]. Coronary artery disease
is the number one killer in diabetic patients. Diabetic
patients are having coronary artery disease at a
younger age, more diffuse and more extensively [4–
6]. Besides this, diabetic patients have also an
increased risk to develop congestive heart failure
compared to a non-diabetic population [7]. Several
pathophysiologic mechanisms are responsible for
this: The higher incidence of ischemic heart disease
in diabetes, the presence of hypertension and the
development of speciﬁc diabetic cardiomyopathy [8].
Because silent ischemia is present in up to 60% of
patients with diabetes, non-invasive imaging with
stress echocardiography nuclear perfusion imaging or
stress MRI should be used liberally in these patients
before cardiovascular events occur [9]. One can
argue, which technique should be used in selected
patients. In this issue of the International Journal of
Cardiac Imaging O ¨m} ur et al. showed that if nuclear
imaging is used, in diabetic patients the results of
imaging with Thallium 201 and TC-99m Sestamibi
are comparable [10]. This in agreement with earlier
studies performed by Cramer et al. [11] in 1994. He
showed, that in 38 patients referred for evaluation of
chest pain, and had to coronary angiography, the
accuracy of Tc-99 m-sestamibi SPECT and TI-201
SPECT in detecting signiﬁcant coronary artery dis-
ease was 87%. In this study, only two patients were
classiﬁed differently by the two methods. So, no
clinically relevant differences in diagnostic accuracy
were demonstrated between Tc-99 m-sestamibi and
TI-201 SPECT using combined dipyridamole-exer-
cise stress for the evaluation of coronary artery
disease.
Because the sensitivity and speciﬁcity of stress
echocardiography and stress MRI [12, 13] are close
to the values of radionuclide imaging, the choice of
the speciﬁc test is primarily dependent to the
experience of the local centre and the habitus of the
patient. The most important issue, is that silent
ischemia is recognized in diabetic patients and
treatment is started early!.
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